{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:27:47Z","timestamp":1793633267548,"version":"4.5.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To determine phage titers accurately, reproducibly and in a non-laborious and cost-effective manner, we describe the development of a qPCR platform for molecular quantification of five phages present in bacteriophage cocktail 2 (BFC2). We compared the performance of this molecular approach, with regard to quantification and reproducibility, with the standard culture-based double agar overlay method (DAO). We demonstrated that quantification of each of the five phages in BFC2 was possible by means of qPCR, without prior DNA extraction, but yields were significantly higher in comparison to DAO. Although DAO is assumed to provide an indication of the number of infective phage particles, whereas qPCR only provides information on the number of phage genomes, the difference in yield (qPCR\/DAO ratio) was observed to be phage-dependent and appeared rather constant for all phages when analyzing different (freshly prepared) stocks of these phages. While DAO is necessary to determine sensitivity of clinical strains against phages in clinical applications, qPCR might be a valid alternative for rapid and reproducible quantification of freshly prepared stocks, after initial establishment of a correction factor towards DAO.<\/jats:p>","DOI":"10.1038\/s41598-019-50461-0","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T10:03:33Z","timestamp":1569405813000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Development of a qPCR platform for quantification of the five bacteriophages within bacteriophage cocktail 2 (BFC2)"],"prefix":"10.1038","volume":"9","author":[{"given":"Hans","family":"Duyvejonck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Merabishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Pirnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Verbeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0002-024X","authenticated-orcid":false,"given":"Jonas","family":"Van Belleghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Gryp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"De Leenheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Van der Borght","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Van Simaey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Van Mechelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4586-203X","authenticated-orcid":false,"given":"Mario","family":"Vaneechoutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,25]]},"reference":[{"key":"50461_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","volume":"25","author":"KE Kortright","year":"2019","unstructured":"Kortright, K. E., Chan, B. K., Koff, J. L. & Turner, P. E. Phage therapy: A renewed approach to combat antibiotic-resistant bacteria. Cell Host Microbe 25, 219\u2013232 (2019).","journal-title":"Cell Host Microbe"},{"key":"50461_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2217\/fvl.12.24","volume":"7","author":"JP Pirnay","year":"2012","unstructured":"Pirnay, J. P. et al. Introducing yesterday\u2019s phage therapy into today\u2019s medicine. Future Virol. 7, 379\u2013390 (2012).","journal-title":"Future Virol."},{"key":"50461_CR3","doi-asserted-by":"crossref","unstructured":"Bragg, R., van der Westhuizen, W., Lee, J. Y., Coetsee, E. & Boucher, C. Bacteriophages as potential treatment option for antibiotic resistant bacteria. Adv. Exp. Med. Biol. 807, 97\u2013110.","DOI":"10.1007\/978-81-322-1777-0_7"},{"key":"50461_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.12968\/jowc.2016.25.Sup7.S27","volume":"25","author":"R Fish","year":"2016","unstructured":"Fish, R. et al. Bacteriophage treatment of intransigent diabetic toe ulcers: A case series. J. Wound Care 25, 27\u201333 (2016).","journal-title":"J. Wound Care"},{"key":"50461_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1709-y","volume":"21","author":"S Jennes","year":"2017","unstructured":"Jennes, S. et al. Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report. Crit. Care 21, 129 (2017).","journal-title":"Crit. Care"},{"key":"50461_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5144\/0256-4947.2016.216","volume":"36","author":"GR Yilmaz","year":"2016","unstructured":"Yilmaz, G. R. et al. Risk factors for infection with colistin-resistant gram-negative microorganisms: A multicenter study. Ann. Saudi Med. 36, 216\u2013222 (2016).","journal-title":"Ann. Saudi Med."},{"key":"50461_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fmed.2017.00094","volume":"4","author":"P Zhvania","year":"2017","unstructured":"Zhvania, P., Hoyle, N. S., Nadareishvili, L., Nizharadze, D. & Kutateladze, M. Phage therapy in a 16-year-old boy with Netherton syndrome. Front. Med. 4, 94 (2017).","journal-title":"Front. Med."},{"key":"50461_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","volume":"19","author":"P Jault","year":"2019","unstructured":"Jault, P. et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): A randomised, controlled, double-blind phase 1\/2 trial. Lancet Infect. Dis. 19, 35\u201345 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"50461_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.00954-17","volume":"61","author":"RT Schooley","year":"2017","unstructured":"Schooley, R. T. et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob. Agents Chemother. 61, 10 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"50461_CR10","first-page":"652","volume":"57","author":"A Gratia","year":"1936","unstructured":"Gratia, A. Des relations num\u00e9riques entre bact\u00e9ries lysog\u00e8nes et particles de bacteriophage. Ann. Inst. Pasteur 57, 652\u2013676 (1936).","journal-title":"Ann. Inst. Pasteur"},{"key":"50461_CR11","doi-asserted-by":"crossref","unstructured":"Carlson, K. Working with bacteriophages: Common techniques and methodological approaches. Appendix in Bacteriophages: Biology and Applications (Eds Kutter, E. & Sulakvelidze, A.) 437\u2013490 (CRC Press, 2005).","DOI":"10.1201\/9780203491751.ax1"},{"key":"50461_CR12","doi-asserted-by":"publisher","first-page":"e4944","DOI":"10.1371\/journal.pone.0004944","volume":"4","author":"M Merabishvili","year":"2009","unstructured":"Merabishvili, M. et al. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PLoS ONE 4, e4944 (2009).","journal-title":"PLoS ONE"},{"key":"50461_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2144\/03352rr02","volume":"35","author":"DC Edelman","year":"2003","unstructured":"Edelman, D. C. & Barletta, J. Real-time PCR provides improved detection and titer determination of bacteriophage. BioTechniques 35, 368\u2013375 (2003).","journal-title":"BioTechniques"},{"key":"50461_CR14","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.fm.2008.07.004","volume":"25","author":"MC Mart\u00edn","year":"2008","unstructured":"Mart\u00edn, M. C., del Rio, B., Mart\u00ednez, N., Magad\u00e1n, A. H. & Alvarez, M. A. Fast real-time polymerase chain reaction for quantitative detection of Lactobacillus delbrueckii bacteriophages in milk. Food Microbiol. 25, 978\u2013982 (2008).","journal-title":"Food Microbiol."},{"key":"50461_CR15","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/j.1462-2920.2010.02162.x","volume":"12","author":"DJ Rooks","year":"2010","unstructured":"Rooks, D. J. et al. Development and validation of a qPCR-based method for quantifying Shiga toxin-encoding and other lambdoid bacteriophages. Env. Microbiol. 12, 1194\u20131204 (2010).","journal-title":"Env. Microbiol."},{"key":"50461_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1128\/AEM.01391-10","volume":"77","author":"D Verreault","year":"2011","unstructured":"Verreault, D. et al. Detection of airborne lactococcal bacteriophages in cheese manufacturing plants. Appl. Env. Microbiol. 77, 491\u2013497 (2011).","journal-title":"Appl. Env. Microbiol."},{"key":"50461_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4161\/bact.20092","volume":"2","author":"D Refardt","year":"2012","unstructured":"Refardt, D. Real-time quantitative PCR to discriminate and quantify lambdoid bacteriophages of Escherichia coli K-12. Bacteriophage 2, 98\u2013104 (2012).","journal-title":"Bacteriophage"},{"key":"50461_CR18","doi-asserted-by":"publisher","first-page":"e104853","DOI":"10.1371\/journal.pone.0104853","volume":"9","author":"M Merabishvili","year":"2014","unstructured":"Merabishvili, M. et al. Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii. PLoS ONE 9, e104853 (2014).","journal-title":"PLoS ONE"},{"key":"50461_CR19","unstructured":"Adams, M. H. Assay of phages by the agar layer method in Bacteriophages (ed. Adams, M. H.) 450\u2013451 (Interscience Publishers, 1959)."},{"key":"50461_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1471-2180-11-181","volume":"11","author":"R Gallet","year":"2011","unstructured":"Gallet, R., Kannoly, S. & Wang, I.-N. Effects of bacteriophage traits on plaque formation. BMC Microbiol 11, 181 (2011).","journal-title":"BMC Microbiol"},{"key":"50461_CR21","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/v10020064","volume":"10","author":"JP Pirnay","year":"2018","unstructured":"Pirnay, J. P. et al. The magistral phage. Viruses 10, 64 (2018).","journal-title":"Viruses"},{"key":"50461_CR22","doi-asserted-by":"publisher","first-page":"e79010","DOI":"10.1371\/journal.pone.0079010","volume":"8","author":"P Deschaght","year":"2013","unstructured":"Deschaght, P. et al. Is the improvement of CF patients, hospitalized for pulmonary exacerbation, correlated to a decrease in bacterial load? PLoS ONE 8, e79010 (2013).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50461-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50461-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50461-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T14:02:11Z","timestamp":1671285731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50461-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["50461"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-50461-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,25]]},"assertion":[{"value":"17 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13893"}}